Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone marrow mesenchymal stem cell transplantation for chronic complete cervical spinal cord injury
ChiCTR-ONRC-12002478Phase 2Completed
- Sponsor
- Seventh Medical Center of PLA General Hospital
- Start
- Jan 2008
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of autologous bone-marrow mesenchymal stem cells in spinal cord injury (SCI) and cervical spinal cord injury (2 arms), sponsored by Seventh Medical Center of PLA General Hospital. Primary endpoints: AIS grading scale and ASIA score. Started Jan 2008; status: completed.
02
Drugs
autologous bone-marrow mesenchymal stem cells
03
Conditions
spinal cord injury (SCI)cervical spinal cord injury
Beyond the preview
Go deeper on ChiCTR-ONRC-12002478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-12002478.